CCO is an independent medical education company that provides state-of-the-art
medical information to
healthcare professionals through conference coverage and other educational
programs.


Official Online Conference Coverage*
Click to Access
Now Available: Conference Coverage
From AASLD 2008
*CCO is the official provider of online conference coverage of the
2008 Meeting of the American Association for the Study of Liver Diseases (AASLD)
October 31 - November 4, 2008 | San Francisco, California







Click to Access
Video and Audio Highlights


Watch and listen to experts review the most important data from San Francisco,
California
in downloadable video and audio formats.


Click here to browse available Expert Highlights or choose a topic below to
access the format most convenient for you.


Click to Access
Investigational Agents for Viral Hepatitis






Stefan Zeuzem, MD, highlights data from AASLD 2008 on investigational agents for
viral hepatitis, focusing on new targeted therapies for hepatitis C, as well as
markers for HBsAg seroconversion with peginterferon.
To access this Expert Highlight, click here.



This Expert Highlight is located online at:
http://clinicaloptions.com/Hepatitis/Conference%20Coverage/AASLD%202008.aspx



Approved HBV Agents — Click a link below to access a Capsule Summary



Low Rate of HBV Recurrence When Antiviral Therapy and HBIG Given Together as
Prophylaxis After Liver Transplantation




Rituximab Administration Associated With Reactivation of Hepatitis B




Long-term Entecavir Treatment Results in Durable HBV Suppression in
Treatment-Naive, HBeAg-Positive Patients




Clinical Experience in Italy Confirms Efficacy and Low Resistance Rates With
Entecavir in Nucleos(t)ide-Naive Patients With Chronic Hepatitis B




Small Retrospective Study Finds Switching to Tenofovir Possibly a Viable Option
for HBV-Infected Patients With Suboptimal Response to Entecavir




Liver Fibrosis and Cirrhosis Present in Many Non-Asian Patients With Chronic HBV
Infection and Normal or Moderately Elevated ALT Levels




Peginterferon alfa-2a Response Rates in HBeAg-Positive Korean Patients With
Lamivudine Resistance Similar to Lamivudine-Naive Patients




Entecavir Combined With Tenofovir Effective and Well Tolerated in Cirrhotic
HBV-Infected Patients With Multidrug-Resistant HBV




These Capsule Summaries are located online at:
http://clinicaloptions.com/Hepatitis/Conference%20Coverage/AASLD%202008.aspx







Coming soon: CME/CE-certified Expert Analyses












Physicians:
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care
Options, LLC.


Nurses:
Nursing contact hours provided through the cosponsorship of Postgraduate
Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute
for Medicine is accredited as a provider of continuing nursing education by the
American Nurses Credentialing Center's Commission on Accreditation.


Pharmacists:
Postgraduate Institute for Medicine is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education. Pharmacy
credit hours provided through the cosponsorship of Postgraduate Institute for
Medicine and Clinical Care Options, LLC.





Supported by educational grants from Bristol-Myers Squibb, Gilead Sciences,
Merck, Pharmasset, and Vertex.








































CCO is the official provider of online conference coverage of The Liver Meeting®
2008.
http://www.aasld.org








CCO Hepatitis | RSS | Hepatitis Podcasts | Bookstore | Slideset Downloads


To ensure you receive Clinical Care Options educational materials by email,
please add info@... to your contacts or address book.


Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston
White Drive, Suite 110, Reston, VA 20191-5433


Not a member yet? Click here | Unsubscribe from all emails sent from CCO |
Manage email preferences